6/4/2014, GlaxoSmithKline settles charges it unlawfully promoted Advair and other popular drugs


GlaxoSmithKline will pay $105 million [small cost of doing big business] to settle charges that it unlawfully promoted its asthma drug Advair and antidepressants Paxil and Wellbutrin. The payment settles charges brought by 45 state attorneys general.

The attorneys general alleged GSK also illegally marketed a second antidepressant drug, Wellbutrin, to children without FDA approval. GSK also unlawfully marketed Wellbutrin as an “off-label” drug for weight loss and to treat attention deficit disorder, addiction, anxiety and bi-polar disorder.

But it was not fined for using anti-depressants to treat chronic pain?

If you don't comment, I'll just assume you agree with me

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s